2012 Midyear Clinical Meeting
Click here to go to the previous page
Transitioning Through ADHD: Pharmacotherapeutic Management from Childhood to Adulthood
Track:
Education Sessions (CE)
Program Code: 200-L01
Date: Wednesday, December 5, 2012
Time: 2:00 PM to 4:00 PM EST
Location:
Reef D, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Bridget Bradley,
RPh, PharmD, Assistant Professor,
Pacific University School of Pharmacy
|
Dr. Bradley serves as Assistant Professor at Pacific University School of Pharmacy and has experience in working with patients with a range of mental health conditions. She joined Pacific University after completing her PGY-2 in psychiatric pharmacy at Avera Behavioral Health Center. Her current clinical practice site is with Virginia Garcia Memorial Health Center a federally qualified health center in Hillsboro Oregon.
|
|
Dr. Joshua Caballero completed a BA in Psychology from the University of Florida and received his PharmD from the University of Tennessee Health Science Center. Afterwards, he completed a Psychiatric Residency at the University of Texas Health Science Center at San Antonio and a Pharmacotherapy Fellowship at The Ohio State University. He has participated in the DHHS/HACU profession capacity building program and ACCP FIT program. He is currently an Assistant Professor at Nova Southeastern University with practice sites at Jackson Memorial Hospital and Nova Southeastern University.
Academically, Dr. Caballero is a preceptor for students in their Advance Pharmacy Practice Experiences and coordinates one of the Therapeutics sequences and Pharmacy Residency elective course. Dr. Caballero primarily lectures on psychiatric topics including ADHD. His residency course has an over 80% success rate. He has been a past recipient of the yearly Golden Apple Award (2008, 2012), given to the best professor in the College of Pharmacy.
Dr. Caballero is board certified in psychiatric pharmacy and has worked extensively with underserved populations including establishing pharmacy outpatient clinical services. Dr. Caballeros research interests include the effects of psychotropic agents in various populations and their impact on cognition. He has published in the areas of cognitive function, and most recently authored an ADHD chapter in Pediatric Pharmacotherapy. Additionally, he is the primary editor for ASHPs book on securing pharmacy residencies.
|
Clayton English,
PharmD, BCPP, Assistant Professor,
Albany College of Pharmacy & Health Sciences
|
Dr. English received his Bachelor of Science in Pharmacy Studies and his Doctor of Pharmacy at the University of Connecticut. Upon graduation, Dr. English completed a specialty residency in clinical psychopharmacology at Nova Southeastern University in conjunction with the South Florida State Hospital in Pembroke Pines, Florida. Dr. English currently serves as an assistant professor of pharmacy practice at Albany College of Pharmacy & Health Sciences in Colchester, Vermont and is a board certified psychiatric pharmacist at Fletcher Allen Health Care (FAHC) in Burlington, Vermont. FAHC serves as the major academic medical center for the state of Vermont. Dr. Englishs work at FAHC involves providing clinical pharmacy services on FAHCs two adult inpatient psychiatric units.
In addition to providing clinical pharmacy services at FAHC, Dr. English is an adjunct assistant professor in the department of psychiatry at the University of Vermont Medical School. He currently serves as a preceptor for psychiatry residents on their inpatient psychiatry rotation. He also serves as a preceptor for an elective rotation in psychopharmacology and as a preceptor in the outpatient psychopharmacology clinic.
In conjunction with his clinical pharmacy services and teaching he provides at the hospital, Dr. English coordinates and teaches a variety of courses in the area of psychiatric therapeutics and psychopharmacology. He is also a primary preceptor for 4th year pharmacy students on clerkship for inpatient psychiatry.
|
David Fuentes,
PharmD, BCPP, Associate Professor & Department Chair,
Manchester University College of Pharmacy
|
Dr. David G. Fuentes is an Associate Professor at Manchester University College of Pharmacy and serves as department chair of pharmacy practice. He has served the academy close to a decade, and has served patients with psychiatric disorders and consulted for patients with advanced age as part of his clinical career. Being part of the academy has helped him develop his leadership skills and has allowed him the privilege to take part in the development of pharmacy professionals. His teaching interests include cultural competence, practice management, psychiatry and internal medicine. Additionally, he is passionate about faculty development, leadership, curricular design, mentorship development, and enjoys developing relationships with colleagues founded on mutual respect and reciprocity. He serves as an associate editor for Health and Interprofessional Practice journal.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
David Fuentes,
PharmD, BCPP, Associate Professor & Department Chair,
Manchester University College of Pharmacy
|
Dr. David G. Fuentes is an Associate Professor at Manchester University College of Pharmacy and serves as department chair of pharmacy practice. He has served the academy close to a decade, and has served patients with psychiatric disorders and consulted for patients with advanced age as part of his clinical career. Being part of the academy has helped him develop his leadership skills and has allowed him the privilege to take part in the development of pharmacy professionals. His teaching interests include cultural competence, practice management, psychiatry and internal medicine. Additionally, he is passionate about faculty development, leadership, curricular design, mentorship development, and enjoys developing relationships with colleagues founded on mutual respect and reciprocity. He serves as an associate editor for Health and Interprofessional Practice journal.
|
Description
Introduction to ADHD Pharmacotherapy and Considerations, David Fuentes, PharmD, BCPP
Recommendations for Adding a Second Agent Differentiating (Comparing and Contrasting) Between Childhood and Adulthood Symptoms of ADHD, Clayton D. English, PharmD, BCPP
Recommendations for Adding a Second Agent for Treating Patients Already Using an Agent for ADHD, Joshua Caballero, PharmD
Recommendations on Treating Adult ADHD Patients with Common Comorbid Axis I Disorders, Bridget Bradley, RPh, PharmD
- Apply patient-specific adherence barriers and the co-morbidities to the selection of the most beneficial attention deficit hyperactivity disorder (ADHD) treatment options.
- Design a patient-specific treatment plan for the management of the presenting ADHD symptoms/chief complaint.
- Evaluate a patient's ADHD medication regimen customized to personal adherence practices, labs, and concurrent medical illnesses.
- Interpret population safety data to determine the use of the most optimal agents for the management of a health system's ADHD medication formulary.
